Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia [Phase 1, Phase 2]
A Phase 1/2 trial of radiolabeled monoclonal antibody therapy with peripheral stem cell transplantation for lymphoma or Waldenström's macrog…
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma [Phase 1, Phase 2]
This document reports results from Phase 1 and Phase 2 trials of a monoclonal antibody in combination with interleukin-2 in patients with le…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Evaluation of KX2-391 in Patients With Advanced Malignancies [Phase 1]
This entry reports completion of a Phase 1 trial evaluating KX2-391 in patients with advanced solid tumors and lymphoma.
-
CLINICAL_TRIALS trial_result · 2011-06-07Clinical Trial Update: Study of Plitidepsin in Combination With Sorafenib or Gemcitabine in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial update of plitidepsin in combination with sorafenib or gemcitabine in patients with advanced solid tumors or lymphoma…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy [Phase 3]
Phase 3 clinical trial evaluating epoetin alfa for the treatment of anemia in cancer patients receiving chemotherapy; study completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer [Phase 2]
Phase 2 trial evaluating fludarabine, busulfan, and anti-lymphocyte globulin followed by donor stem cell transplant in older patients with h…
-
CLINICAL_TRIALS withdrawal · 2011-05-16Clinical Trial Update: Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours [Phase 1]
The phase 1 trial of an mTOR kinase inhibitor in advanced solid tumors and lymphomas was withdrawn; no further results are reported.
-
CLINICAL_TRIALS trial_result · 2011-05-12Clinical Trial Update: Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer [Phase 2]
A Phase 2 trial evaluated the combination of interleukin-2 and interferon alfa in adults with metastatic cancer. The study encompassed multi…
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma [Phase 1]
Phase 1 trial update evaluating a combination of pemetrexed and oxaliplatin in patients with metastatic solid tumors or lymphoma; the study …
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 trial update reports results of a combination chemotherapy regimen in patients with advanced cancer, spanning several hematologic …
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT [Phase 1, Phase 2]
A completed Phase I/II trial investigated pentostatin with tacrolimus and low-dose methotrexate to prevent graft-versus-host disease after m…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Cancer [Phase 1, Phase 2]
Clinical trial NCT00004105 completed a phase 1/2 study of combination chemotherapy for advanced cancer. The trial included conditions such a…
-
CLINICAL_TRIALS trial_result · 2011-03-28Clinical Trial Update: Alemtuzumab and Pentostatin In T-cell Neoplasms [Phase 2]
Phase 2 trial evaluating alemtuzumab in combination with pentostatin for T-cell neoplasms was terminated; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy, radiation therapy, and umbilical cord blood transplantation in patients with hematologic can…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Chemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic Cancer [Phase 1]
This is a Phase 1 trial evaluating chemotherapy in combination with amifostine and filgrastim in patients with recurrent or metastatic cance…
-
CLINICAL_TRIALS trial_result · 2011-03-07Clinical Trial Update: Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders [Phase 2]
Completed Phase 2 study evaluating donor umbilical cord blood transplantation for patients with leukemia, lymphoma, and certain nonmalignant…
-
CLINICAL_TRIALS research · 2011-03-07Clinical Trial Update: Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases
This update notes termination of a clinical trial evaluating an immunologic diagnostic blood test intended to predict donor stem cell transp…
-
CLINICAL_TRIALS trial_result · 2011-03-02Clinical Trial Update: KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment [Phase 1]
Phase 1 clinical trial update on KX2-391 in patients with advanced solid tumors or lymphoma that did not respond to prior treatment.
-
CLINICAL_TRIALS trial_result · 2011-03-01Clinical Trial Update: Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer [Phase 1]
Phase 1 clinical trial evaluating chemotherapy followed by stem cell transplantation in children with brain and other central nervous system…
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Heparin or Enoxaparin in Patients With Cancer
A completed clinical trial evaluated the use of heparin versus enoxaparin in cancer patients to assess outcomes related to thrombosis and ca…
-
CLINICAL_TRIALS trial_result · 2011-02-18Clinical Trial Update: Réa-MiniMax: Severe Acute Respiratory Failure in Hematology and Cancer Patients Without Bronchoalveolar Lavage [Phase 3]
Phase 3 clinical trial update for Réa-MiniMax addressing severe acute respiratory failure in patients with hematologic cancers (lymphoma and…
-
CLINICAL_TRIALS trial_result · 2011-02-17Clinical Trial Update: Using Fludarabine and Melphalan Conditioning Regimen for CLL,Lymphoma,Multiple Myeloma [Phase 2]
Phase 2 clinical trial update on using a conditioning regimen of fludarabine and melphalan for patients with chronic lymphocytic leukemia, l…
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignancies [Phase 1, Phase 2]
This update presents safety and pharmacokinetic data from a Phase 1/2 trial of orally administered gallium maltolate in refractory malignanc…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Phase I, Open-label, Dose Escalation of AZD4877 in Hematologic Malignancies [Phase 1]
Phase I, open-label, dose-escalation trial of AZD4877 in hematologic malignancies focusing on lymphoma has been terminated.
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating a pentostatin-alemtuzumab preparative regimen for allogeneic peripheral blood stem cell transplantation; the study …